← Leaderboards
Christopher M Snyder
Thomas Jefferson University
$6,371,518
Attributed
$7,361,767
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,361,767 · 7
By mechanism
R01$6,418,842 · 3
R56$364,250 · 1
R03$308,675 · 2
K22$270,000 · 1
Top collaborators
- Noreen J Hickok3 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Noreen J Hickok$7,657,282
- Lauren Jo Delaney$1,784,635
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsImmuneInfectionPreventCytomegalovirusT-LymphocyteCytomegalovirus InfectionsViralVirusImmune SystemPathogenEnvironmentImmune ResponseTissuesSiteMucosal SiteSeriesCell PhysiologyProductionVaccinesCytokineHerpesviridaeFetusInstitute Of Medicine (U.S.)
Grant awards (20)
The joint environment and periprosthetic joint infection$611,177
R01 · FY2025 · AR
The joint environment and periprosthetic joint infection$686,259
R01 · FY2024 · AR
T cell control of MCMV and tissue-localized immune suppression$530,193
R01 · FY2024 · AI · contact PI
The joint environment and periprosthetic joint infection$683,063
R01 · FY2023 · AR
T cell control of MCMV and tissue-localized immune suppression$563,467
R01 · FY2023 · AI · contact PI
An animal model for cytomegalovirus-induced pathology in the developing retina$78,000
R03 · FY2023 · AI · contact PI
T cell control of MCMV and tissue-localized immune suppression$530,193
R01 · FY2022 · AI · contact PI
An animal model for cytomegalovirus-induced pathology in the developing retina$78,000
R03 · FY2022 · AI · contact PI
T cell control of MCMV and tissue-localized immune suppression$531,097
R01 · FY2021 · AI · contact PI
T cell control of MCMV and tissue-localized immune suppression$551,268
R01 · FY2020 · AI · contact PI
Selection of inflationary and tissue-resident T cells during MCMV infection$387,500
R01 · FY2018 · AI · contact PI
Selection of inflationary and tissue-resident T cells during MCMV infection$387,500
R01 · FY2017 · AI · contact PI
Selection of inflationary and tissue-resident T cells during MCMV infection$387,500
R01 · FY2016 · AI · contact PI
Selection of inflationary and tissue-resident T cells during MCMV infection$387,500
R01 · FY2015 · AI · contact PI
Selection of inflationary and tissue-resident T cells during MCMV infection$182,125
R01 · FY2014 · AI · contact PI
Synergy between BRAF inhibition, tumor-localized T cells and a persistent vaccine$75,175
R03 · FY2014 · CA · contact PI
Selection of inflationary and tissue-resident T cells during MCMV infection$364,250
R56 · FY2013 · AI · contact PI
Synergy between BRAF inhibition, tumor-localized T cells and a persistent vaccine$77,500
R03 · FY2013 · CA · contact PI
Maintenance of the virus-specific T cell equillibrium in chronic MCMV infection$108,000
K22 · FY2011 · AI · contact PI
Maintenance of the virus-specific T cell equillibrium in chronic MCMV infection$162,000
K22 · FY2010 · AI · contact PI